ANIL KHURANA: Open Payments
NPI 1871807933 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 48 payments from 7 companies in 2025. Trend: 2023 $371 · 2024 $761 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $202 |
| E.R. Squibb & Sons, L.L.C. | 7 | $175 |
| Lundbeck LLC | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Alkermes, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, ARISTADA, UZEDY.
Industry payments across CA — which companies pay providers there.
